Low risk of hepatitis B reactivation in patients with severe COVID‐19 who receive immunosuppressive therapy

enthalten in: Journal of Viral Hepatitis | 2021

von Rodríguez‐Tajes, S. | Miralpeix, A. | Costa, J. | +6

Efficacy of an accelerated double‐dose hepatitis B vaccine regimen in patients with cirrhosis

enthalten in: Journal of Viral Hepatitis | 2021

von Rodríguez‐Tajes, S. | Pocurull, A. | Lens, S. | +6

Chronic genotype 1 hepatitis C along with cirrhosis drives a persistent imprint in virus‐specific CD8+ T cells after direct‐acting antiviral therapies

enthalten in: Journal of Viral Hepatitis | 2020

von Perpiñán, E. | Pérez‐Del‐Pulgar, S. | Londoño, M. | +8